Genzyme (also known as Genzyme Transgenics Corp or GTC Biotherapeutics) was an American biotechnology company based in Cambridge, Massachusetts. From its acquisition in 2011 to 2022 …

Aug 2, 2025 · Genzyme was founded in 1981, aiming to apply advanced biotechnology to develop treatments for diseases. Its founders recognized a need for innovative approaches to conditions that …

Nov 18, 2024 · Genzyme's growth story showcases a biotech company that thrived through diversification and innovative financing strategies. Despite challenges, including its reliance on rare …

Feb 3, 2022 · Eleven years after Sanofi bought Genzyme for about $20.1 billion, the parent company said Thursday it will no longer call its specialty care unit Sanofi Genzyme ― just Sanofi, as part of a ...

Genzyme Corporation (Genzyme) is a biotechnology company. The Company's product and service portfolio is focused on rare genetic disease disorders, renal diseases, orthopaedics, cancer,...

The TSI acquisition was made by Genzyme Transgenics Corp., created by Genzyme in 1993 to promote and develop technology combining recombinant microbiology and experimental embryology to …

Jan 21, 2025 · In a warning letter dated 15 January, the FDA wrote that it had serious concerns about manufacturing issues with Sanofi’s former subsidiary Genzyme Corporation’s manufacturing facility …

Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. It is engaged in the …

Oct 16, 2025 · Explore Genzyme's in-depth company profile, including funding details, key investors, leadership, and acquisitions.

Genzyme(also known as Genzyme Transgenics Corpor GTC Biotherapeutics) was an American biotechnology company based in Cambridge, Massachusetts. From its acquisition in 2011 to 2022 …